176 related articles for article (PubMed ID: 37670372)
1. Severe hypercalcemia due to metastatic pancreatic neuroendocrine tumor: a case report.
Behdadnia A; Jeddi M
J Med Case Rep; 2023 Sep; 17(1):400. PubMed ID: 37670372
[TBL] [Abstract][Full Text] [Related]
2. Case Report: Unmasking Hypercalcemia in Patients With Neuroendocrine Neoplasms. Experience From Six Italian Referral Centers.
Giannetta E; Sesti F; Modica R; Grossrubatscher EM; Guarnotta V; Ragni A; Zanata I; Colao A; Faggiano A
Front Endocrinol (Lausanne); 2021; 12():665698. PubMed ID: 34093441
[TBL] [Abstract][Full Text] [Related]
3. Malignant hypercalcaemia related to parathyroid hormone-related peptide (PTHrP) secretion from a metastatic pancreatic neuroendocrine tumour (NET).
Symington M; Davies L; Kaltsas G; Weickert MO
BMJ Case Rep; 2017 Mar; 2017():. PubMed ID: 28331027
[TBL] [Abstract][Full Text] [Related]
4. Humoral hypercalcemia of malignancy caused by parathyroid hormone-related peptide-secreting neuroendocrine tumors. Report of six cases.
Milanesi A; Yu R; Wolin EM
Pancreatology; 2013; 13(3):324-6. PubMed ID: 23719609
[TBL] [Abstract][Full Text] [Related]
5. Unusual complication of a pancreatic neuroendocrine tumor presenting with malignant hypercalcemia.
Kanakis G; Kaltsas G; Granberg D; Grimelius L; Papaioannou D; Tsolakis AV; Öberg K
J Clin Endocrinol Metab; 2012 Apr; 97(4):E627-31. PubMed ID: 22319031
[TBL] [Abstract][Full Text] [Related]
6. Somatostatin receptor expression in a parathyroid hormone-related peptide-secreting pancreatic neuroendocrine tumour causing severe hypercalcaemia.
Müssig K; Petersenn S; Wehrmann M; Horger M; Vierling P; Häring HU; Gallwitz B
Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):719-23. PubMed ID: 17625444
[TBL] [Abstract][Full Text] [Related]
7. Reversal of Severe and Refractory Humoral Hypercalcemia With 177Lu-Octreotate Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumor of the Pancreas.
Iliuta IA; Beauregard JM; Couture F; Douville P; Mac-Way F
Clin Nucl Med; 2015 Sep; 40(9):e448-50. PubMed ID: 26053724
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic Neuroendocrine Tumor With Humoral Hypercalcemia and High Tumor PD-L1 Score.
Copur MS; Vargas L; Wedel W; Merani S; Cushman-Vokoun A; Drincic A
Oncology (Williston Park); 2020 Dec; 34(12):548-552. PubMed ID: 33395496
[TBL] [Abstract][Full Text] [Related]
9. PTHrP, calcitonin and calcitriol in a case of severe, protracted and refractory hypercalcemia due to a pancreatic neuroendocrine tumor.
Van den Eynden GG; Neyret A; Fumey G; Rizk-Rabin M; Vermeulen PB; Bouizar Z; Body JJ; Dirix LY
Bone; 2007 Apr; 40(4):1166-71. PubMed ID: 17188588
[TBL] [Abstract][Full Text] [Related]
10. Protracted hypocalcaemia following a single dose of denosumab in humoral hypercalcaemia of malignancy due to PTHrP-secreting neuroendocrine tumour.
Teng J; Abell S; Hicks RJ; Hofman MS; Sachithanandan N; McKelvie P; MacIsaac RJ
Clin Endocrinol (Oxf); 2014 Dec; 81(6):940-2. PubMed ID: 24890549
[No Abstract] [Full Text] [Related]
11. Hypercalcemia of malignancy caused by parathyroid hormone-related peptide-secreting pancreatic neuroendocrine tumors (PTHrP-PNETs): Case Report.
Pitts S; Mahipal A; Bajor D; Mohamed A
Front Oncol; 2023; 13():1197288. PubMed ID: 37377908
[TBL] [Abstract][Full Text] [Related]
12. A Case of a Rare Parathyroid Hormone (PTH)-Producing Neuroendocrine Tumor.
Quinn CD; Chaudhary F; Gould-Simon A; Chen B; Bhandal HS; Chaudhary U
Am J Case Rep; 2022 Jul; 23():e935783. PubMed ID: 35849548
[TBL] [Abstract][Full Text] [Related]
13. [Unusual cause of hypercalcemia in pregnancy].
Mehl L; Schrader J; Winterberg T; Daniels T; Gross A; Weidner U; Clauditz TS; Lock G
Z Gastroenterol; 2021 Feb; 59(2):143-148. PubMed ID: 33556973
[TBL] [Abstract][Full Text] [Related]
14. Concurrent primary hyperparathyroidism and humoral hypercalcemia of malignancy in a patient with multiple endocrine neoplasia type 1.
Milanesi A; Yu R; Geller SA; Burton D; Deftos LJ; Wolin EM
Pancreas; 2011 May; 40(4):634-7. PubMed ID: 21483254
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic neuroendocrine tumor associated with humoral hypercalcemia of malignancy and carcinoid tumor: a case report and review of the literature.
Shah RH; Martinez D
Pancreas; 2013 Apr; 42(3):549-51. PubMed ID: 23211368
[No Abstract] [Full Text] [Related]
16. Paraneoplastic hypercalcemia in a patient with adenosquamous cancer of the colon.
Thompson JT; Paschold EH; Levine EA
Am Surg; 2001 Jun; 67(6):585-8. PubMed ID: 11409809
[TBL] [Abstract][Full Text] [Related]
17. Everolimus Related Fulminant Hepatitis in Pancreatic Neuroendocrine Tumor With Liver Metastases: A Case Report and Literature Review.
Chang SC; Tsai CY; Liu KH; Wang SY; Hsu JT; Yeh TS; Yeh CN
Front Endocrinol (Lausanne); 2021; 12():639967. PubMed ID: 33868173
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic neuroendocrine tumor with extensive vascularisation and parathyroid hormone-related protein (PTHrP)--associated hypercalcemia of malignancy.
Clemens P; Gregor M; Lamberts R
Exp Clin Endocrinol Diabetes; 2001; 109(7):378-85. PubMed ID: 11573150
[TBL] [Abstract][Full Text] [Related]
19. Malignant islet cell tumor associated with hypercalcemia.
Mao C; Carter P; Schaefer P; Zhu L; Dominguez JM; Hanson DJ; Appert HE; Kim K; Howard JM
Surgery; 1995 Jan; 117(1):37-40. PubMed ID: 7809834
[TBL] [Abstract][Full Text] [Related]
20. Long-term follow-up of two patients with metastatic neuroendocrine tumours treated with octreotide.
van de Loosdrecht AA; van Bodegraven AA; Sepers JM; Sindram JW
Neth J Med; 1998 Sep; 53(3):118-23. PubMed ID: 9803143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]